<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05112562</url>
  </required_header>
  <id_info>
    <org_study_id>20.172</org_study_id>
    <nct_id>NCT05112562</nct_id>
  </id_info>
  <brief_title>Attentional Bias Modification Training for E-cigarette Users</brief_title>
  <official_title>Attentional Bias Modification Training for E-cigarette Users</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Wisconsin, Milwaukee</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Wisconsin, Milwaukee</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Aims are to (1) evaluate attentional bias to e-cigarette cues between the intervention and&#xD;
      control groups at post-intervention as compared to the pre-intervention; and (2) test the&#xD;
      feasibility and efficacy of the intervention at post-intervention. To accomplish these aims,&#xD;
      a theory-driven parallel, controlled 2-arm randomized clinical trial will be conducted with&#xD;
      young adult e-cigarette users (approximately N = 50). Outcomes are attentional bias to&#xD;
      e-cigarette cues and abstinence outcomes including nicotine dependence, and arousal/urges for&#xD;
      e-cigarette use.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">June 9, 2021</start_date>
  <completion_date type="Anticipated">December 31, 2022</completion_date>
  <primary_completion_date type="Anticipated">May 31, 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Attentional bias to e-cigarette cues</measure>
    <time_frame>Pre-training</time_frame>
    <description>Attentional bias measured by a cueing task, dot-probe task, and/or eye-tracking task</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Attentional bias to e-cigarette cues</measure>
    <time_frame>1-month follow up</time_frame>
    <description>Attentional bias measured by a cueing task, dot-probe task, and/or eye-tracking task</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Attentional bias to e-cigarette cues</measure>
    <time_frame>2-months follow up</time_frame>
    <description>Attentional bias measured by a cueing task, dot-probe task, and/or eye-tracking task</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Attentional bias to e-cigarette cues</measure>
    <time_frame>4-months follow up</time_frame>
    <description>Attentional bias measured by a cueing task, dot-probe task, and/or eye-tracking task</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Arousal/urges for e-cigarette use</measure>
    <time_frame>Pre-training</time_frame>
    <description>Electrodermal reactivity (measured by a skin response sensor)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Arousal/urges for e-cigarette use</measure>
    <time_frame>Pre-training</time_frame>
    <description>Heartrate variability (measured by a EKG recording device)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Arousal/urges for e-cigarette use</measure>
    <time_frame>Pre-training</time_frame>
    <description>Subjective urges for ENDS use (measured by E-cigarette Use Patterns questionnaire)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Arousal/urges for e-cigarette use</measure>
    <time_frame>Pre-training</time_frame>
    <description>Penn State E-Cigarette Dependence Index</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Arousal/urges for e-cigarette use</measure>
    <time_frame>1-month follow up</time_frame>
    <description>Electrodermal reactivity (measured by a skin response sensor)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Arousal/urges for e-cigarette use</measure>
    <time_frame>1-month follow up</time_frame>
    <description>Heartrate variability (measured by a EKG recording device)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Arousal/urges for e-cigarette use</measure>
    <time_frame>1-month follow up</time_frame>
    <description>Subjective urges for ENDS use (measured by E-cigarette Use Patterns questionnaire)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Arousal/urges for e-cigarette use</measure>
    <time_frame>1-month follow up</time_frame>
    <description>Penn State E-Cigarette Dependence Index</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Arousal/urges for e-cigarette use</measure>
    <time_frame>2-month follow up</time_frame>
    <description>Electrodermal reactivity (measured by a skin response sensor)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Arousal/urges for e-cigarette use</measure>
    <time_frame>2-month follow up</time_frame>
    <description>Heartrate variability (measured by a EKG recording device)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Arousal/urges for e-cigarette use</measure>
    <time_frame>2-month follow up</time_frame>
    <description>Subjective urges for ENDS use (measured by E-cigarette Use Patterns questionnaire)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Arousal/urges for e-cigarette use</measure>
    <time_frame>2-month follow up</time_frame>
    <description>Penn State E-Cigarette Dependence Index</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Arousal/urges for e-cigarette use</measure>
    <time_frame>4-month follow up</time_frame>
    <description>Electrodermal reactivity (measured by a skin response sensor)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Arousal/urges for e-cigarette use</measure>
    <time_frame>4-month follow up</time_frame>
    <description>Heartrate variability (measured by a EKG recording device)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Arousal/urges for e-cigarette use</measure>
    <time_frame>4-month follow up</time_frame>
    <description>Subjective urges for ENDS use (measured by E-cigarette Use Patterns questionnaire)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Arousal/urges for e-cigarette use</measure>
    <time_frame>4-month follow up</time_frame>
    <description>Penn State E-Cigarette Dependence Index</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">50</enrollment>
  <condition>E-cigarette Use</condition>
  <condition>Tobacco Use Cessation</condition>
  <arm_group>
    <arm_group_label>Computerized attentional bias modification training</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo attention control training</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Computerized attentional bias modification training</intervention_name>
    <description>In intervention is designed to train participants to disengage attention from potent e-cigarette cues and is based on the well-established attention retraining paradigm for other psychopathologies.</description>
    <arm_group_label>Computerized attentional bias modification training</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Placebo attention control training</intervention_name>
    <description>This control training is very similar to the intervention's overall task structure and stimuli. The only difference is that the this control program is designed to exert no systematic manipulation on the attention deployment pattern between the two stimulus categories, thereby yielding no significant impact on the level of attentional bas toward ENDS-related cues</description>
    <arm_group_label>Placebo attention control training</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  18 and 29 years&#xD;
&#xD;
          -  Those who use ENDS exclusively, not combining with other tobacco, for 3 consecutive&#xD;
             months&#xD;
&#xD;
          -  Those who own a smartphone.&#xD;
&#xD;
        Exclusion criteria:&#xD;
&#xD;
          -  Current medication or psychosocial treatment for ENDS dependence&#xD;
&#xD;
          -  Serious alcohol-use problems (â‰¥ 26 points on the Alcohol Use Disorders Identification&#xD;
             Test)&#xD;
&#xD;
          -  Ophthalmic conditions impeding eye-tracking&#xD;
&#xD;
          -  Current psychiatric/psychosocial treatment for other mental health disorders in the&#xD;
             DSM-5 (e.g., schizophrenia)&#xD;
&#xD;
          -  Pregnancy.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>29 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Seok Hyun Gwon, PhD, RN</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Wisconsin, Milwaukee</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Seok Hyun Gwon, PhD, RN</last_name>
    <phone>414-229-6462</phone>
    <email>gwon@uwm.edu</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Han Joo Lee, PhD</last_name>
    <email>leehj@uwm.edu</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>University of Wisconsin-Milwaukee</name>
      <address>
        <city>Milwaukee</city>
        <state>Wisconsin</state>
        <zip>53211</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Seok Hyun Gwon, PhD, RN</last_name>
      <phone>414-229-6462</phone>
      <email>gwon@uwm.edu</email>
    </contact>
    <contact_backup>
      <last_name>Han Joo Lee, PhD</last_name>
      <email>leehj@uwm.edu</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>October 2021</verification_date>
  <study_first_submitted>September 22, 2021</study_first_submitted>
  <study_first_submitted_qc>October 27, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">November 9, 2021</study_first_posted>
  <last_update_submitted>October 27, 2021</last_update_submitted>
  <last_update_submitted_qc>October 27, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">November 9, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

